Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,939
Closed -$388K 136
2024
Q1
$388K Buy
2,939
+126
+4% +$15.5K 0.23% 70
2023
Q4
$307K Buy
2,813
+28
+1% +$2.91K 0.19% 78
2023
Q3
$287K Buy
2,785
+212
+8% +$22.9K 0.2% 80
2023
Q2
$297K Buy
2,573
+564
+28% +$64K 0.21% 79
2023
Q1
$214K Sell
2,009
-15
-0.7% -$1.62K 0.21% 94
2022
Q4
$225K Buy
+2,024
New +$207K 0.23% 90
2021
Q4
Sell
-2,971
Closed -$223K 123
2021
Q3
$223K Buy
+2,971
New +$226K 0.19% 127
2020
Q1
Sell
-2,763
Closed -$240K 167
2019
Q4
$240K Buy
+2,763
New +$227K 0.22% 128

Other funds holding MRK

Beam Wealth Advisors's MRK Position: Q2 2024 in Review

Beam Wealth Advisors sold out of Merck (MRK) in Q2 2024, closing a stake of 2,939 shares — an estimated $388K sold.

Beam Wealth Advisors first reported a position in MRK in Q4 2019 and held it in 8 quarters. The position peaked at $388K in Q1 2024. 3,545 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • Beam Wealth Advisors reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • Beam Wealth Advisors sold 2,939 Merck shares in Q2 2024, an estimated $388K.
  • Beam Wealth Advisors first reported a position in Merck in Q4 2019 and held it in 8 quarters.
  • Beam Wealth Advisors's Merck position peaked at $388K in Q1 2024.
  • 3,545 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Beam Wealth Advisors's 13F filing for Q2 2024, filed 7 Aug 2024.